Search for Moderna in the web?

Moderna (15)

Moderna COVID-19 vaccine appears safe, shows signs of working in older adults: study | Reuters

ca.reuters.com
Submitted 21 day(s) ago by system

Results from an early safety study of Moderna Inc's coronavirus vaccine candidate in older adults showed that it produced virus-neutralizing antibodies at levels similar to those seen in younger adults, with side effects roughly on par with high-dose flu shots,...

Moderna’s coronavirus vaccine won’t be ready by US election, says CEO | South China Morning Post

www.scmp.com
Submitted 21 day(s) ago by system

Meanwhile, FDA expands investigation into other leading candidate by AstraZeneca and Oxford after serious illness during trial.

Moderna sees 20 million doses of COVID-19 vaccine candidate by year end | Reuters

www.reuters.com
Submitted 32 day(s) ago by system

Moderna Inc said on Friday it was on track to produce 20 million doses of its experimental coronavirus vaccine by the end of the year, while maintaining its goal of readying 500 million to 1 billion doses in 2021.

Moderna Tumbles Amid Insider Sales and Covid Vaccine Jitters - Bloomberg

www.bloomberg.com
Submitted 46 day(s) ago by system

Moderna Inc. shares slid 3.5% on Friday as unease mounted about the biotech’s Covid-19 vaccine trial fueled by ongoing insider shares sales and an enrollment slowdown.

Moderna charging far more for its experimental coronavirus vaccine than rival treatments - CBS News

www.cbsnews.com
Submitted 77 day(s) ago by system

Drugmaker is charging $32 to $37 for initial doses, more than triple the cost of other vaccines being tested.

Debate begins for who's first in line for COVID-19 vaccine | KOMO

komonews.com
Submitted 80 day(s) ago by system

(AP) — Who gets to be first in line for a COVID-19 vaccine? U. S. health authorities hope by late next month to have some draft guidance on how to ration initial doses, but it’s a vexing decision. “Not everybody’s going to like the answer,” Dr. Francis Collins, director of the National Institutes of Health, recently told one of the advisory groups the government asked to help decide. “There will be many people who feel that they should have been at the top of the list. ”

Start Vaccinating Now!

www.forbes.com
Submitted 81 day(s) ago by system

Development of new Covid-19 vaccines is proceeding at a furious pace, which is good news for the world.

COVID-19 vaccine made by Moderna, National Institutes of Health poised for final testing in US - ABC7 Los Angeles

abc7.com
Submitted 98 day(s) ago by system

Early-stage testing showed the first COVID-19 vaccine tested in the U.S. revved up people's immune systems the way scientists had hoped.

COVID-19 vaccine made by Moderna, National Institutes of Health poised for final testing in US - 6abc Philadelphia

6abc.com
Submitted 99 day(s) ago by system

Early-stage testing showed the first COVID-19 vaccine tested in the U.S. revved up people's immune systems the way scientists had hoped.

First Seattle volunteer in human COVID-19 vaccine trials says she feels 'fantastic' | KOMO

komonews.com
Submitted 104 day(s) ago by system

The race to develop a COVID-19 vaccine is heating up globally and right here in our area. In Seattle, we’ve got a lot of companies and volunteers doing their part to try and help. “It’s been 16 weeks since I had the first dose," said Jennifer Haller of Ballard. "I feel fantastic. " On March 16, Haller, a 43-year-old a tech startup operations manager, became the first person in the country to get injected with the experimental COVID-19 vaccine.

Moderna execs dumped nearly $30 million of stock after coronavirus vaccine news - CNN

edition.cnn.com
Submitted 152 day(s) ago by system

Moderna's stock price skyrocketed as much as 30% on Monday after the biotech company announced promising early results for its coronavirus vaccine. As ordinary investors piled in, two insiders were quietly heading for the exits.

A Coronavirus Vaccine is “Just The Tip Of The Iceberg For Moderna,” One Analyst Says. Here’s Why - Barron's

www.barrons.com
Submitted 154 day(s) ago by system

Moderna’s development of a successful Sars-Cov-2 vaccine would validate the company’s technology and expand its platform, says Piper Sandler analyst Ted Tenthoff.

First Person Injected With Trial Coronavirus Vaccine In Seattle

www.forbes.com
Submitted 219 day(s) ago by system

43-year old Jennifer Haller from Seattle was the first person to be injected with a new trial coronavirus vaccine on Monday. Researchers will follow her and 44 other people for 12 months to evaluate the vaccine.

Submit your article?

Submit your articles for more traffic to your website!

Submit
© 2019 topfind88.com. Imprint, All rights reserved.